NEW YORK (GenomeWeb News) – Leerink Swann analyst Isaac Ro said in a research report published today that he believes a major acquisition by Thermo Fisher Scientific is "likely in the near term, with possible targets coming in the areas of Bioprocess tools, HPLC, or Diagnostics."

He noted that Thermo's shares have lagged the market recently due to ongoing speculation about a major acquisition for the firm. Ro said that given Thermo's broad distribution channel, the company "could choose any of these areas and recognize material benefits."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.